Theralase Change In Working Capital from 2010 to 2024
| TLT Stock | CAD 0.26 0.01 3.70% |
Change In Working Capital | First Reported 2002-03-31 | Previous Quarter -46.1 K | Current Value 574.7 K | Quarterly Volatility 369.2 K |
Check Theralase Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theralase Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 150.8 K, Interest Expense of 31.9 K or Other Operating Expenses of 4.2 M, as well as many indicators such as Price To Sales Ratio of 35.14, Dividend Yield of 0.0 or PTB Ratio of 13.26. Theralase financial statements analysis is a perfect complement when working with Theralase Technologies Valuation or Volatility modules.
Theralase | Change In Working Capital |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.